Case Report: Moxibustion-induced burns leading to disseminated methicillin-resistant Staphylococcus aureus infection in a patient with type 2 diabetes mellitus - Top-Institutions - MDSpire

Case Report: Moxibustion-induced burns leading to disseminated methicillin-resistant Staphylococcus aureus infection in a patient with type 2 diabetes mellitus

  • By

  • Hong Liang

  • Zhen-Fang Mao

  • Jin-Yu Huang

  • Yang Yang

  • Xue-Mei Li

  • Jie-Feng Mao

  • Qi Li

  • Yun-Bo Zhang

  • Wu-Xiao Wei

  • May 26, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Medicine – The Johns Hopkins Hospital
    Johns Hopkins Medicine – The Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Infectious Disease

  • #2

    Duke Health – Duke University Hospital
    Duke Health – Duke University Hospital

    Durham, North Carolina

    Key Differentiators

    • Infectious Disease

  • #3

    Saint-Louis University Hospital
    Saint-Louis University Hospital

    Sassari, Italy

    Key Differentiators

    • Infectious Disease

  • #4

    Santa Maria della Misericordia Hospital
    Santa Maria della Misericordia Hospital

    Perugia, Italy

    Key Differentiators

    • Infectious Disease

Original Source(s)

Case Report: Moxibustion-induced burns leading to disseminated methicillin-resistant Staphylococcus aureus infection in a patient with type 2 diabetes mellitus

  • by Hong Liang, Zhen-Fang Mao, Jin-Yu Huang, Yang Yang, Xue-Mei Li, Jie-Feng Mao, Qi Li, Yun-Bo Zhang, Wu-Xiao Wei

  • May 26, 2026

Related Content

An Uncommon Instance of Mycotic Pseudoaneurysm in the Common Femoral Artery Due to Septic Ankle Arthritis: Considerations for Surgical and Endovascular Approaches

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Extracellular vesicles in atopic dermatitis: unraveling pathogenic mediators and engineering therapeutic vectors